Results 151 to 160 of about 4,122,734 (351)
Frontiers in AllergyIn the Asia-Pacific region, there is limited data on the full extent of the burden of severe asthma, as well as a lack of clear guidance on improving care standards.
Mariko Siyue Koh +12 more
doaj +1 more source
Update on Biological Therapeutics for Asthma [PDF]
, 2010 : Asthma poses a significant burden on patients, families, health care providers, and the medical system. While efforts to standardize care through guidelines have expanded, difficulty in managing severe asthma has encouraged research about its ...
Bruce S. Bochner, Marisha L. Cook
core +1 more source
Biological treatments for severe asthma: A major advance in asthma care.
Allergology International, 2019 Asthma is a heterogeneous disease with considerable variability noted in disease severity, patterns of airway inflammation, and achievement of disease control on current medications. An absence of disease control is most frequently noted in patients with
W. Busse
semanticscholar +1 more source
Rationale of New Grading System: Central Compartment Atopic Disease
International Forum of Allergy &Rhinology, EarlyView.ABSTRACT Background Central compartment atopic disease (CCAD) has recently been recognized as a distinct phenotype within the spectrum of type 2–dominant chronic rhinosinusitis (CRS). Although international guidelines highlight polypoid changes in the central nasal cavity, standardized diagnostic and classification criteria are still lacking.
Ramón Moreno‐Luna +11 more
wiley +1 more source
European Clinical Respiratory Journal, 2018 Although a minority of asthma patients suffer from severe asthma, they represent a major clinical challenge in terms of poor symptom control despite high-dose treatment, risk of exacerbations, and side effects.
Celeste Porsbjerg +17 more
doaj +1 more source
International Forum of Allergy &Rhinology, EarlyView.ABSTRACT Background Although shifts in nasal microbiota have been well‐documented in inflammatory upper airway conditions, microbiota tumor‐associated alterations remain uncharacterized. This study is the first to compare sinonasal microbiota profiles of patients with malignant tumors (MT), benign tumors (BT), and controls, offering insights into tumor‐
Evan A. Patel +13 more
wiley +1 more source
Mepolizumab and COPD in Real Life
Open Respiratory Archives, 2022 Fernando Revuelta-Salgado +3 more
doaj +1 more source
Remotely Monitored Therapy and Nitric Oxide Suppression Identifies Nonadherence in Severe Asthma
American Journal of Respiratory and Critical Care Medicine, 2019 Rationale: Poor adherence is common in difficult‐to‐control asthma. Distinguishing patients with difficult‐to‐control asthma who respond to inhaled corticosteroids (ICS) from refractory asthma is an important clinical challenge.
L. Heaney +8 more
semanticscholar +1 more source